17β-estradiol increases nitric oxide and prostaglandin I2 production by cultured human uterine arteries only in histologically normal specimens

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 2, 2001, Pages 240-249

  Obayashi, Satoshi ^a   Beppu, Masashi ^a   Aso, Takeshi ^a   Goto, Moritaka ^a   Azuma, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

17 estradiol; Cyclic nucleotides; Human uterine artery; Intimal hyperplasia; Nitric oxide; Prostaglandin I2

Indexed keywords

ESTRADIOL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NUCLEIC ACID; NUCLEOTIDE; PROSTACYCLIN;

ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; ENDOTHELIUM; ESTRADIOL BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; UTERINE ARTERY;

ADULT; ARTERIES; CULTURE TECHNIQUES; CYCLIC GMP; EPOPROSTENOL; ESTRADIOL; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; MUSCLE RELAXATION; NITRIC OXIDE; TUNICA INTIMA; UTERUS; VASODILATION;

EID: 0034913546     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200108000-00010     Document Type: Article

References (29)

1. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
2. Myocardial infarction and the use of estrogen and estrogen-progesterone in postmenopausal women
3. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two-year follow-up study
4. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
5. The pathogenesis of atherosclerosis-an update
6. Syndromes of accelerated atherosclerosis
7. Role of endothelium in the human uterine arteries during normal menstrual cycle
8. 2 and nitric oxide
9. Enzymatic determination of total serum cholesterol
10. Colorimetric method for estimation of serum triglycerides
11. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries
12. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
13. 2 and prostacyclin
14. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
15. Estrogen upregulates cyclooxygenase-1 gene expression in ovine pulmonary artery endothelium
16. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
17. Endothelium-dependent inhibition of platelet aggregation
18. The antiaggregating properties of vascular endothelium: Interaction between prostacyclin and nitric oxide
19. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide gene
20. Repeated endothelial removal augments intimal thickening and attenuates EDRF release
21. Nitric oxide: An endogenous modulator of leukocyte adhesion
22. 2 in cultured rabbit aortic smooth muscle cells
23. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein
24. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women
25. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption
26. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells
27. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia
28. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effect on NO synthase
29. Endothelial regulation of vascular contraction in radial and internal mammary arteries